Association of Beneficiary-Level Risk Factors and Hospital-Level Characteristics With Medicare Part B Drug Spending Differences Between 340B and Non-340B Hospitals

IMPORTANCE: Critics of the federal 340B Drug Pricing Program raised concerns that the program might provide financial incentives for participating hospitals to prescribe more and/or more expensive drugs because the revenue generated from Medicare reimbursement exceeds the purchase price by a substan...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yufei, Xu, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857681/
https://www.ncbi.nlm.nih.gov/pubmed/35179584
http://dx.doi.org/10.1001/jamanetworkopen.2022.0045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857681/
https://www.ncbi.nlm.nih.gov/pubmed/35179584
http://dx.doi.org/10.1001/jamanetworkopen.2022.0045

Ejemplares similares